Results 31 to 40 of about 2,423,192 (204)

A computational model of contributors to pulmonary hypertensive disease: impacts of whole lung and focal disease distributions

Pulmonary Circulation, 2021
Pulmonary hypertension has multiple etiologies and so can be difficult to diagnose, prognose, and treat. Diagnosis is typically made via invasive hemodynamic measurements in the main pulmonary artery and is based on observed elevation of mean pulmonary ...
Behdad Shaarbaf Ebrahimi, Merryn H. Tawhai, Haribalan Kumar, Kelly S. Burrowes, Eric A. Hoffman, Margaret L. Wilsher, David Milne, Alys R. Clark   +7 more
doaj   +1 more source

Riociguat use in sickle cell related chronic thromboembolic pulmonary hypertension: A case series

Pulmonary Circulation, 2018
Adults with sickle cell disease can develop pulmonary hypertension from a multitude of etiologies. Classified as WHO Group 5, there are no therapies approved for the treatment of sickle cell disease-pulmonary hypertension.
Nargues A. Weir, Anna Conrey, Denise Lewis, Alem Mehari   +3 more
doaj   +1 more source

Balloon Pulmonary Angioplasty: State of the Art

Interventional Cardiology: Reviews, Research, Resources, 2021
Balloon pulmonary angioplasty (BPA) is a novel technique for the treatment of chronic thromboembolic pulmonary hypertension. While cardiologists need no introduction to the concept of balloon angioplasty, BPA has its own particular challenges.
John G Coghlan, Alexander MK Rothman, Stephen P Hoole   +2 more
doaj   +1 more source

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension [PDF]

, 2011
Background: Endothelin-1 signalling plays an important role in pathogenesis of pulmonary hypertension. Although different endothelin-A receptor antagonists are developed, a novel therapeutic option to cure the disease is still needed.
Norbert Weissmann, Sydykov, Akylbek, Brandes, Ralf, Schermuly, Ralph T., Hossein A Ghofrani, Janssen, Wiebke, Seeger Werner, Ralf P Brandes, Neil Davie, Dahal, Bhola K., Davie, Neil, Janssen Wiebke, Davie Neil, Ghofrani Hossein A, Seeger, Werner, Cornitescu, Teodora, Brandes Ralf P, Cornitescu Teodora, Kosanovic, Djuro, Kojonazarov, Baktybek, Werner Seeger, Friedrich Grimminger, Ghofrani, Hossein Ardeschir, Grimminger, Friedrich, Dahal Bhola K, Djuro Kosanovic, Baktybek Kojonazarov, Teodora Cornitescu, Schermuly Ralph T, Sydykov Akylbek, Wiebke Janssen, Grimminger Friedrich, Akylbek Sydykov, Kojonazarov Baktybek, Weissmann Norbert, Himal Luitel, Luitel Himal, Ralph T Schermuly, Luitel, Himal, Weißmann, Norbert, Bhola K Dahal, Kosanovic Djuro   +41 more
core   +2 more sources

Biomarkers of collagen turnover and wound healing in chronic thromboembolic pulmonary hypertension patients before and after pulmonary endarterectomy

, 2023
Background: In chronic thromboembolic pulmonary hypertension (CTEPH), fibrotic remodeling of tissue and thrombi contributes to disease progression. Removal of the thromboembolic mass by pulmonary endarterectomy (PEA) improves hemodynamics and right ...
Andersen, Stine, Andersen, Mads J. nsson, Mellemkjær, S. ren, Andersen, Asger, Bogaard, Harm Jan, Nielsen-Kudsk, Jens Erik, Genovese, Federica, Braams, Natalia, Reese-Petersen, Alexander Lynge   +8 more
core   +1 more source

Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism [PDF]

, 2018
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but feared long-term complication of acute pulmonary embolism (PE), although CTEPH may occur in patients with no history of symptomatic venous thromboembolism.
M. Delcroix, Klok, F A, Bogaard, H.J., Delcroix, M., Bogaard, H J, Delcroix, M, Klok, F.A., F.A. Klok, H.J. Bogaard   +8 more
core   +1 more source

Time trends of pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension

Pulmonary Circulation, 2021
Chronic thromboembolic pulmonary hypertension is considered as a rare but severe complication after acute pulmonary embolism and is potentially curable by pulmonary endarterectomy.
Lukas Hobohm, Karsten Keller, Thomas Münzel, Stavros V. Konstantinides, Mareike Lankeit   +4 more
doaj   +1 more source

The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension

, 2016
Chronic thromboembolic pulmonary hypertension (CTEPH) is a late sequel of venous thromboembolism that cannot be completely reproduced in animal models. The prevalence of CTEPH in humans is estimated at roughly 17-20 per million; however, partly because ...
Vonk Noordegraaf, Anton, Peter Dorfmüller, Dorfmüller, Peter, Irene M. Lang, Anton Vonk Noordegraaf, Lang, Irene M   +5 more
core   +1 more source

Healthcare utilization in chronic thromboembolic pulmonary hypertension after acute pulmonary embolism [PDF]

, 2018
Essentials Diagnostic delay of chronic thromboembolic pulmonary hypertension (CTEPH) is long. We explored healthcare utilisation of patients diagnosed with CTEPH after pulmonary embolism.
Symersky, P., Huisman, M.V., Meijboom, L J, Klok, F A, Bogaard, H.J., Huisman, M V, Hout, W.B. van den, Vonk-Noordegraaf, A, Ende-Verhaar, Y.M., Vonk-Noordegraaf, A., Ende-Verhaar, Y M, Symersky, P, Meijboom, L.J., Bogaard, H J, van den Hout, W B, Klok, F.A.   +15 more
core   +1 more source

Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension-A single-center experience in Taiwan

, 2017
Background/Purpose: Pulmonary endarterectomy (PEA) is a potentially curative surgical procedure for patients with chronic thromboembolic pulmonary hypertension. The aim of this study is to review our institutional experience with this operation. ;Methods:
林彥宏;黃書健;盤松青;徐紹勛;賴鴻緒;郭順文, Luo, Wei-Cheng;Huang, Shu-Chien;Lin, Yen-Hung;Lai, Hong-Shiee;Kuo, Shuenn-Wen;Pan, Sung-Ching;Hsu, Hsao-Hsun   +1 more
core   +1 more source